CoreWeave, Inc. is a strong AI infrastructure buy after record Q3 growth, reduced risk, and major contracts. Click here to ...
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, welcomes U.S.
With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trialsNEW YORK, Dec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results